109 related articles for article (PubMed ID: 2347712)
1. Reduction of spinal metastases after preemptive irradiation in prostatic cancer.
Kaplan ID; Valdagni R; Cox RS; Bagshaw MA
Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1019-25. PubMed ID: 2347712
[TBL] [Abstract][Full Text] [Related]
2. Radiation treatment of prostate bone metastases and the biological considerations.
Bagshaw MA; Kaplan ID; Valdagni R; Cox RS
Adv Exp Med Biol; 1992; 324():255-68. PubMed ID: 1283500
[TBL] [Abstract][Full Text] [Related]
3. Nonrandomized evaluation of pelvic lymph node irradiation in localized carcinoma of the prostate.
Perez CA; Michalski J; Brown KC; Lockett MA
Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):573-84. PubMed ID: 8948341
[TBL] [Abstract][Full Text] [Related]
4. [10-year results of using segmental pelvic irradiation combined with local irradiation of the prostate in patients with prostate cancer with multiple bone metastases].
Metelev VV
Vopr Onkol; 2015; 61(1):137-40. PubMed ID: 26016160
[TBL] [Abstract][Full Text] [Related]
5. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
[TBL] [Abstract][Full Text] [Related]
6. Reduced incidence of bone metastases in irradiated areas after external radiation therapy of prostatic carcinoma.
Jacobsson H; Näslund I
Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1297-303. PubMed ID: 2045303
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
Wang-Chesebro A; Xia P; Coleman J; Akazawa C; Roach M
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):654-62. PubMed ID: 17011444
[TBL] [Abstract][Full Text] [Related]
8. [The remineralization of the vertebral metastases of breast carcinoma after radiotherapy].
Wachenfeld I; Sanner G; Böttcher HD; Kollath J
Strahlenther Onkol; 1996 Jun; 172(6):332-41. PubMed ID: 8677507
[TBL] [Abstract][Full Text] [Related]
9. Clinical response of pelvic and para-aortic lymphadenopathy to a radiation boost in the definitive management of locally advanced cervical cancer.
Rash DL; Lee YC; Kashefi A; Durbin-Johnson B; Mathai M; Valicenti R; Mayadev JS
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):317-22. PubMed ID: 23906933
[TBL] [Abstract][Full Text] [Related]
10. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z
Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322
[TBL] [Abstract][Full Text] [Related]
11. [Radiotherapy of bone metastases from cervical cancer].
Monzen Y; Nakanishi K; Ajimu A; Morikawa M; Hayashi K
Gan No Rinsho; 1989 Mar; 35(4):467-71. PubMed ID: 2469805
[TBL] [Abstract][Full Text] [Related]
12. IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk.
Ahmed RS; Kim RY; Duan J; Meleth S; De Los Santos JF; Fiveash JB
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):505-12. PubMed ID: 15380585
[TBL] [Abstract][Full Text] [Related]
13. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage.
Spratt DE; Vargas HA; Zumsteg ZS; Golia Pernicka JS; Osborne JR; Pei X; Zelefsky MJ
Eur Urol; 2017 Jan; 71(1):37-43. PubMed ID: 27523595
[TBL] [Abstract][Full Text] [Related]
14. Impact of surgical staging in evaluating the radiotherapeutic outcome in RTOG #77-06, a phase III study for T1BN0M0 (A2) and T2N0M0 (B) prostate carcinoma.
Asbell SO; Martz KL; Shin KH; Sause WT; Doggett RL; Perez CA; Pilepich MV
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):769-82. PubMed ID: 9531360
[TBL] [Abstract][Full Text] [Related]
15. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
[TBL] [Abstract][Full Text] [Related]
16. Study on the distribution features of bone metastases in prostate cancer.
Wang C; Shen Y
Nucl Med Commun; 2012 Apr; 33(4):379-83. PubMed ID: 22293499
[TBL] [Abstract][Full Text] [Related]
17. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
18. Comparison of bone scintigraphy and 18F-FDG PET-CT in a prostate cancer patient with osteolytic bone metastases.
Ozcan Kara P; Kara T; Kara Gedik G; Sari O; Sahin O
Rev Esp Med Nucl; 2011; 30(2):94-6. PubMed ID: 21342722
[TBL] [Abstract][Full Text] [Related]
19. Anatomical Patterns of Recurrence Following Biochemical Relapse in the Dose Escalation Era of External Beam Radiotherapy for Prostate Cancer.
Zumsteg ZS; Spratt DE; Romesser PB; Pei X; Zhang Z; Kollmeier M; McBride S; Yamada Y; Zelefsky MJ
J Urol; 2015 Dec; 194(6):1624-30. PubMed ID: 26165583
[TBL] [Abstract][Full Text] [Related]
20. Clinical application of high-dose, image-guided intensity-modulated radiotherapy in high-risk prostate cancer.
Bayley A; Rosewall T; Craig T; Bristow R; Chung P; Gospodarowicz M; Ménard C; Milosevic M; Warde P; Catton C
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):477-83. PubMed ID: 19733014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
